Company profile
TauC3 Biologics Limited company profile
TAUC3BIO CORPORATION is a privately-held biopharmaceutical company focused on the development of innovative high precision immunotherapies for the treatment of tauopathies such as Alzheimer’s disease (AD) and Progressive Supranuclear Palsy (PSP). Its patented platform relates to the development of monoclonal antibodies (mAbs) targeting neurotoxic tau protein fragments, especially tauC3, with mAbs that do not bind to full-length tau (FLT). It was founded in 2019 and headquartered in Holborn, Camden.
Business identity
- Website
- https://tauc3bio.com/
- Phone number
- 203-743-3938
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2019-01-01, Year
Headquarters
- Headquarters
- Holborn, England, United Kingdom
- Postal code
- EC4A 3TW
- Country code
- GB
- Continent
- Europe